Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Bates, Shannon M

Middeldorp, Saskia

Rodger, Marc

James, Andra H

Greer, Ian

Netherlands

2017-09-10T18:34:06Z

2017-09-10T18:34:06Z

2016-01

Venous thromboembolism (VTE), which may manifest as pulmonary embolism (PE) or deep vein thrombosis (DVT), is a serious and potentially fatal condition. Treatment and prevention of obstetric-related VTE is complicated by the need to consider fetal, as well as maternal, wellbeing when making management decisions. Although absolute VTE rates in this population are low, obstetric-associated VTE is an important cause of maternal morbidity and mortality. This manuscript, initiated by the Anticoagulation Forum, provides practical clinical guidance on the prevention and treatment of obstetric-associated VTE based on existing guidelines and consensus expert opinion based on available literature where guidelines are lacking.

https://www.ncbi.nlm.nih.gov/pubmed/26780741

10.1007/s11239-015-1309-0

1573-742X

https://hdl.handle.net/10161/15529

eng

Springer Science and Business Media LLC

J Thromb Thrombolysis

10.1007/s11239-015-1309-0

Anticoagulants

Deep vein thrombosis

Obstetric

Pregnancy

Prophylaxis

Pulmonary embolism

Venous thromboembolism

Female

Humans

Practice Guidelines as Topic

Pregnancy

Pregnancy Complications, Cardiovascular

Venous Thromboembolism

Venous Thrombosis

Guidance for the treatment and prevention of obstetric-associated venous thromboembolism.

Journal article

James, Andra H|0000-0003-4570-6595

https://www.ncbi.nlm.nih.gov/pubmed/26780741

92

128

1

Clinical Science Departments

Duke

Medicine

Medicine, Hematology

Midwifery Service

Obstetrics and Gynecology

Obstetrics and Gynecology, Maternal Fetal Medicine

School of Medicine

Published

41